CClinicalTrials.gg
Sign In
Not yet recruitingNCT06985719APA-SAFEUpdated May 22, 2025

Effectiveness of Adapted Physical Activity Programs in Preventing Falls in People Aged Over 65

An observational study in Adapted Physical Activity, sponsored by Centre Médical Porte Verte. Not yet recruiting. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2025-05-22.

Sponsored by Centre Médical Porte Verte · Observational

From the registry’s dates

  • Primary completion was expected by Nov 2025, 10 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
65 Years and older
Sex
All
01

Study summary

The objective of this study is to evaluate the effectiveness of Adapted Physical Activity (APA) programs offered by Sport-Health Centers (MSS) in reducing the risk of falls in the elderly.

Read the detailed description

The effectiveness of adapted physical activity in preventing falls will be assessed by the evolution of SPPB before and after APA.

Evaluate the impact of APA on physical tests such as the UGT, the single-legged support test, to predict the risk of falling.

  • Evaluate the impact of APA on risk factors associated with the risk of falling, such as fear of falling, overall perception of one's health, and depression.

All tests will be assessed at baseline and at the final visit 3 months after APA

02

Conditions studied

  • Adapted Physical Activity
03

In context

Lead sponsor

Centre Médical Porte Verte is the lead sponsor of 8 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

This study aims to target people aged over 65, considered to be at risk of falling.

Several methods have been validated in the existing literature to screen these patients. The chosen method is the Global Guide for Falls Prevention

Inclusion criteria

  • People at risk of falling People practicing an APA program for 3 months Persons who have given their consent to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Patient refusal to participate in the study Absolute or relative contraindication to APA Persons under guardianship Non-affiliation to a social security scheme
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. SPPB Short Physical Performance Battery

    This composite score is based on three tests: a balance test, a walking speed test, and the chair rise test

    Time frame: Twice throughout study at baseline and 3 months after intervention

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06985719
Lead sponsor
Centre Médical Porte Verte
Responsible party
Sponsor
First posted
May 22, 2025
Start date
Sep 1, 2025 (estimated)
Primary completion
Nov 30, 2025 (estimated)
Completion
Dec 30, 2025 (estimated)
Last update
May 22, 2025

Study contacts

Margaux MARCAL
Contact
marcal.margaux@gmail.com
06.33.29.04.32 ext. 0033
Fatima Zohra IZEDAREN
Contact
Fatima-Zohra.Izedaren@lpv.univi.fr
01 39 63 74 51 ext. 0033

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Centre Médical Porte Verte

Start the discussion